[Contribution to the treatment of serous or purulent bronchial hypersecretion in acute and chronic bronchopneumopathies].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001982:Bronchial Diseases / Q000188:drug therapy*; D002908:Chronic Disease; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007827:Laryngitis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014050:Toluene / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000814:Aniline Compounds; D000996:Antitussive Agents; D005100:Expectorants; D014050:Toluene
Contributo al trattamento dell'ipersecrezione bronchiale, sierosa o puruloide, nelle broncopneumopatie acute e croniche.